Oncology Equipment & Supplies In Africa

The most comprehensive, high-performance protein biomarker panels available for oncology studies. The flexibility and scalability of our Olink® Explore platform can be utilized either to screen our entire library of 3072 assays, or in studies that focus on one or several of the eight Explore 384-plex panels that make up the Explore 3072 protein library. ...

Neutropenia and neuropathy can be serious side-effects associated with paclitaxel chemotherapy. While hematological toxicities can be addressed, there is no good solution for chemotherapy induced peripheral neuropathy, which is frequent, may be debilitating and can persist or appear after ...

VesiCulture (BCG Culture) For the treatment of Bladder ...

In addition to the traditional drugs used in the treatment of oncological diseases, the frequency of which is increasing day by day, we supply global oncological drugs with smart drug technology and deliver them to the patients under favorable ...

Targeted therapies are revolutionizing oncology. Patients with chronic myeloid leukemia treated with the tyrosine kinase inhibitors (TKI) now have life expectancies approaching that of the general population. Imatinib (Gleevec®, Gilvec®) the first TKI approved has substantial efficacy in chronic myeloid leukemia (CML) and gastrointestinal stromal ...

Riverpoint offers Round and Square Hub Needles designed and manufactured for ease of use and optimum ...

However, around tumors, Tregs create an immunosuppressive environment and block the work of Teffs to do what they do well – kill cancer cells. So, targeting depletion of Tregs to control tumors has emerged as an area of interest in oncology over the past several years. ...

Riverpoint offers Brachytherapy Grids; disposable template grids for prostate brachytherapy. They stand as a high quality solution for easy needle insertion. ...

Lung cancer is a metastatic cancer which the cancer cells are developed in the bronchial tubes or alveoli and grow along the blood vessel or lymphatic vessel. There are two types of lung cancer based on the sizes and shape of the cancer cell; non-small cell lung cancer (NSCLC) takes 75% and small cell lung cancer takes 25%. Usually, it is hard to find lung cancer in the early stage and is ...

For the radio oncology and medical imaging industries, particle and photon beam delivery are essential components in many of the most sophisticated machines and equipment. From medical research to therapeutics to diagnostics, accelerator technology powers a wide range of modern health care applications. ...

NRAS mutation is found in several cancers such as melanoma (13~25%), colorectal cancer (1~6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is know that the drug response against colorectal cancer medicine such as Erbitux and Cetuximab decreased and the prognosis of the metastatic colorectal cancer patient is bad if the patient has NRAS mutation. Recently, there ...

Keller provides medical device and equipment manufacturing for imaging and radio oncology including proton therapy, linac delivered radiotherapy, PET and MRI. We bring expertise in cGMP regulatory environments. Projects include accelerator, cyclotron and magnet-based equipment for imaging or therapeutic ...

Designed for patient comfort during dialysis, oncology, and chemotherapy treatments. For treatments that require substantial chair time, there is no better option for patient comfort than the TRIAD. Developed and adjusted with feedback from patients and healthcare professionals, the TRIAD was designed with all users in ...

Promotes the generation of cancer-specific effector T cell (Teff) in lymph nodes, and induces the activation and proliferation of tumor-infiltrating Teff and NK cells. Controls the immuno-suppressive function of regulatory T cells (Tregs) in tumor microenvironment (TME). Restores T cell function and anti-cancer immune responses in TME. Secures its safety in GLP toxicity ...

Senti Bio believes there are several advantages that NK cells confer in relation to other potential immune cell types in oncology: innate killing, immune activation, previously validated efficacy and safety, and broad patient access since they may be delivered rapidly to patients in an off-the-shelf manner and in outpatient settings. ...

Cancer is the leading cause of death in Japan, with approximately 90% of those deaths said to be caused by solid ...

Mechanism: ATM inhibitor; Area under investigation: glioblastoma; Date commenced phase: Q2 2018; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule Status ...

TAGRAXOFUSP is a novel targeted therapy directed to the IL-3 receptor α (CD123), a target present on a wide range of malignancies including Blastic Plasmacytoid Dendritic Nell Neoplasm (BPDCN). It comprises human IL-3 recombinantly fused to a truncated diphtheria toxin (DT) payload engineered such that IL-3 replaces the native DT receptor-binding domain. The IL-3 domain of TAGRAXOFUSP ...

Low profile design – streamlined design helps make dressing simple and efficient and improves patient comfort during long infusion times. Simple safety device activation – clinician-friendly and easy to use; audible click lets you know the needle is locked and enclosed during activation. Non-coring siliconized needle – minimizes irritation while the port is being accessed or ...

Mechanism: CDK9 inhibitor Area under investigation: haematalogical malignancies Date commenced phase: Q4 2017 Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule Status change: New to Phase ...